NCT00501579CompletedPhase 3
Study of Difluprednate in the Treatment of Uveitis
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Sirion Therapeutics, Inc.
- Locations
- 1
Study Overview
Brief Summary
The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Masking
- Double
Eligibility Criteria
- Ages
- 2 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosis of endogenous anterior uveitis in at least 1 eye
Exclusion Criteria
- •Presence of intermediate uveitis, posterior uveitis or panuveitis
- •Corneal abrasion
- •Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease
- •Allergy to similar drugs, such as other corticosteroids
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)InflammationNCT00616070Sirion Therapeutics, Inc.120
Completed
Phase 3
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)InflammationNCT00616993Sirion Therapeutics, Inc.120
Completed
Phase 4
Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery.CataractNCT04631315Laboratorios Poen255
Completed
Phase 2
Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsDry Eye DiseaseNCT01276223Alcon Research722
Completed
Phase 2
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative InflammationInflammationNCT00406497Sirion Therapeutics, Inc.24